<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Community:</title>
  <link rel="alternate" href="http://hdl.handle.net/20.500.12323/5721" />
  <subtitle />
  <id>http://hdl.handle.net/20.500.12323/5721</id>
  <updated>2026-04-03T08:39:16Z</updated>
  <dc:date>2026-04-03T08:39:16Z</dc:date>
  <entry>
    <title>Сравнительное изучение основных параметров иммуного статуса и антител к инсулину у больных сахарном диабетом</title>
    <link rel="alternate" href="http://hdl.handle.net/20.500.12323/7719" />
    <author>
      <name>Халилова, И.С.</name>
    </author>
    <author>
      <name>Гельфгат, Е.Б.</name>
    </author>
    <author>
      <name>Джохаридзе, Т.З.</name>
    </author>
    <author>
      <name>Джавадов, С.А.</name>
    </author>
    <id>http://hdl.handle.net/20.500.12323/7719</id>
    <updated>2024-11-05T07:42:12Z</updated>
    <published>1993-01-01T00:00:00Z</published>
    <summary type="text">Title: Сравнительное изучение основных параметров иммуного статуса и антител к инсулину у больных сахарном диабетом
Authors: Халилова, И.С.; Гельфгат, Е.Б.; Джохаридзе, Т.З.; Джавадов, С.А.</summary>
    <dc:date>1993-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Разработка экспериментальной модели иммуносорбента для удаления антител к инсулину из плазмы крови</title>
    <link rel="alternate" href="http://hdl.handle.net/20.500.12323/7718" />
    <author>
      <name>Халилова, И.С.</name>
    </author>
    <author>
      <name>Джохаридзе, Т.З.</name>
    </author>
    <author>
      <name>Гельфгат, Е.Б.</name>
    </author>
    <author>
      <name>Джавадов, С.А.</name>
    </author>
    <id>http://hdl.handle.net/20.500.12323/7718</id>
    <updated>2024-11-05T07:36:46Z</updated>
    <published>1994-01-01T00:00:00Z</published>
    <summary type="text">Title: Разработка экспериментальной модели иммуносорбента для удаления антител к инсулину из плазмы крови
Authors: Халилова, И.С.; Джохаридзе, Т.З.; Гельфгат, Е.Б.; Джавадов, С.А.</summary>
    <dc:date>1994-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Ceruloplasmin Is an Endogenous Inhibitor of Myeloperoxidase</title>
    <link rel="alternate" href="http://hdl.handle.net/20.500.12323/7405" />
    <author>
      <name>Chapman, Anna L. P.</name>
    </author>
    <author>
      <name>Mocatta, Tessa J.</name>
    </author>
    <author>
      <name>Shiva, Sruti</name>
    </author>
    <author>
      <name>Seidel, Antonia</name>
    </author>
    <author>
      <name>Chen, Brian</name>
    </author>
    <author>
      <name>Khalilova, Irada</name>
    </author>
    <author>
      <name>Paumann-Page, Martina E.</name>
    </author>
    <author>
      <name>Jameson, Guy N. L.</name>
    </author>
    <author>
      <name>Winterbourn, Christine C.</name>
    </author>
    <author>
      <name>Kettle, Anthony J.</name>
    </author>
    <id>http://hdl.handle.net/20.500.12323/7405</id>
    <updated>2024-03-18T10:46:56Z</updated>
    <published>2013-01-10T00:00:00Z</published>
    <summary type="text">Title: Ceruloplasmin Is an Endogenous Inhibitor of Myeloperoxidase
Authors: Chapman, Anna L. P.; Mocatta, Tessa J.; Shiva, Sruti; Seidel, Antonia; Chen, Brian; Khalilova, Irada; Paumann-Page, Martina E.; Jameson, Guy N. L.; Winterbourn, Christine C.; Kettle, Anthony J.
Abstract: Myeloperoxidase is a neutrophil enzyme that promotes oxidative stress in numerous inflammatory pathologies. It uses hydrogen peroxide to catalyze the production of strong oxidants including chlorine bleach and free radicals. A physiological defense against the inappropriate action of this enzyme has yet to be identified. We found that myeloperoxidase oxidized 75% of the ascorbate in plasma from ceruloplasmin knock-out mice, but there was no significant loss in plasma from wild type animals. When myeloperoxidase was added to human plasma it became bound to other proteins and was reversibly inhibited. Ceruloplasmin was the predominant protein associated with myeloperoxidase. When the purified proteins were mixed, they became strongly but reversibly associated. Ceruloplasmin was a potent inhibitor of purified myeloperoxidase, inhibiting production of hypochlorous acid by 50% at 25 nm. Ceruloplasmin rapidly reduced Compound I, the Fe(V) redox intermediate of myeloperoxidase, to Compound II, which has Fe(IV) in its heme prosthetic groups. It also prevented the fast reduction of Compound II by tyrosine. In the presence of chloride and hydrogen peroxide, ceruloplasmin converted myeloperoxidase to Compound II and slowed its conversion back to the ferric enzyme. Collectively, our results indicate that ceruloplasmin inhibits myeloperoxidase by reducing Compound I and then trapping the enzyme as inactive Compound II. We propose that ceruloplasmin should provide a protective shield against inadvertent oxidant production by myeloperoxidase during inflammation.</summary>
    <dc:date>2013-01-10T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Hypochlorous acid inactivates myeloperoxidase inside phagocytosing neutrophils</title>
    <link rel="alternate" href="http://hdl.handle.net/20.500.12323/6791" />
    <author>
      <name>Paumann-Page, Martina</name>
    </author>
    <author>
      <name>V. Ashby, Louisa</name>
    </author>
    <author>
      <name>Khalilova, Irada</name>
    </author>
    <author>
      <name>Magon, Nicholas J.</name>
    </author>
    <author>
      <name>Hofbauer, Stefan</name>
    </author>
    <author>
      <name>Paton, Louise N.</name>
    </author>
    <author>
      <name>Furtmüller, Paul G.</name>
    </author>
    <author>
      <name>Obinger, Christian</name>
    </author>
    <author>
      <name>Kettle, Anthony J.</name>
    </author>
    <id>http://hdl.handle.net/20.500.12323/6791</id>
    <updated>2023-09-04T09:05:13Z</updated>
    <published>2023-12-01T00:00:00Z</published>
    <summary type="text">Title: Hypochlorous acid inactivates myeloperoxidase inside phagocytosing neutrophils
Authors: Paumann-Page, Martina; V. Ashby, Louisa; Khalilova, Irada; Magon, Nicholas J.; Hofbauer, Stefan; Paton, Louise N.; Furtmüller, Paul G.; Obinger, Christian; Kettle, Anthony J.
Abstract: When neutrophils phagocytose bacteria, they release myeloperoxidase (MPO) into phagosomes to catalyse the&#xD;
conversion of superoxide to the potent antimicrobial oxidant hypochlorous acid (HOCl). Here we show that&#xD;
within neutrophils, MPO is inactivated by HOCl. In this study, we aimed to identify the effects of HOCl on the&#xD;
structure and function of MPO, and determine the enzyme’s susceptibility to oxidative inactivation during&#xD;
phagocytosis. When hydrogen peroxide was added to a neutrophil granule extract containing chloride, MPO&#xD;
activity was rapidly lost in a HOCl-dependent reaction. With high concentrations of hydrogen peroxide, western&#xD;
blotting demonstrated that MPO was both fragmented and converted to high molecular weight aggregates. Using&#xD;
the purified enzyme, we showed that HOCl generated by MPO inactivated the enzyme by destroying its prosthetic heme groups and releasing iron. MPO protein was additionally modified by forming high molecular weight&#xD;
aggregates. Before inactivation occurred, MPO chlorinated itself to convert most of its amine groups to&#xD;
dichloramines. When human neutrophils phagocytosed Staphylococcus aureus, they released MPO that was&#xD;
largely inactivated in a process that required production of superoxide. Enzyme inactivation occurred inside&#xD;
neutrophils because it was not blocked when extracellular HOCl was scavenged with methionine. The inactivated&#xD;
enzyme contained a chlorinated tyrosine residue, establishing that it had reacted with HOCl. Our results&#xD;
demonstrate that MPO will substantially inactivate itself during phagocytosis, which may limit oxidant production inside phagosomes. Other neutrophil proteins are also likely to be inactivated. The chloramines formed&#xD;
on neutrophil proteins may contribute to the bactericidal milieu of the phagosome.</summary>
    <dc:date>2023-12-01T00:00:00Z</dc:date>
  </entry>
</feed>

